REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N160 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N160 OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Russian Download a sample report

Apteka N160 OOO is an enterprise based in Russia. Its main office is in Noginsk. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on June 04, 2002. In 2021, the company reported a net sales revenue drop of 41.22%. There was a total negative growth of 56.63% in Apteka N160 OOO’s total assets over the same period.

Headquarters
Sovetskaya, 58
Noginsk; Moscow Oblast; Postal Code: 142400

Contact Details: Purchase the Apteka N160 OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka N160 OOO report to view the information.
Registered Capital:
Purchase the Apteka N160 OOO report to view the information.
Incorporation Date:
June 04, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
45%
Purchase this report to view the information.
45%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Apteka N160 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-41.22%
Total operating revenue
-41.22%
Operating profit (EBIT)
-354.07%
Net Profit (Loss) for the Period
N/A
Total assets
-56.63%
Total equity
88.59%
Operating Profit Margin (ROS)
-16.98%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.6%
Cash Ratio
0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?